BIF - investment in Theianova

Page 1 of 1



22 September 2026
Booster Innovation Fund adds TheiaNova to its investment portfolio

Booster NZ is pleased to announce an investment of $200,000 by its Booster Innovation Fund (BIF) in
TheiaNova, a seed stage company.

Founded on research from the University of Auckland and established in 2022, TheiaNova is developing a
new type of medicated eye drop for keratoconus and related eye conditions where the clear front surface
of the eye becomes thin, changes shape and can cause permanent vision loss. Current treatment options
rely on optical correction or procedures that stop the disease from progressing, but this can be costly,
uncomfortable and with limited accessibility and patient acceptability. TheiaNova’s treatment is designed
to be used by patients themselves at home and aims to regenerate collagen in the cornea, to strengthen
and stabilise the tissue, and prevent further deterioration.

Following this transaction (and issue of additional units to fund the purchase), TheiaNova represents
0.76% of BIF’s investment portfolio which currently has exposure to over 35 active companies, and a net
asset value of $26.4m. This investment aligns with Booster Innovation Fund’s commitment to supporting
innovative New Zealand businesses at the seed of their growth.

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of
the process described in the fund’s Product Disclosure Statement (PDS) that is available at
www.booster.co.nz

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-
innovation-fund.aspx



For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300


About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of
the Booster Group which has been helping New Zealanders save since 1998. The group currently
administers superannuation and investment funds of over $8 billion on behalf of more than 200,000 New
Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property
originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement, please visit
www.booster.co.nz